The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 12:30 - 3:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-parameter flow cytometric analysis of CD161 expression on human peripheral blood leucocyte populations. Human peripheral blood was stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714) or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD161 (or Ig Isotype control staining) versus side light scatter signals (SSC) were derived from gated events with the forward and side light-scatter characteristics of viable leucocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Two-color flow cytometric analysis of CD161 expression on human peripheral blood lymphocytes. Human peripheral blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control or Alexa Fluor® 647 Mouse Anti-Human CD161 antibody (Cat. No. 566708). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-parameter flow-cytometric dot plots showing the correlated expression of CD56 versus CD161 expression (or Ig Isotype control staining) were derived from events gated with forward and side light-scatter characteristics of viable human peripheral blood lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The HP-3G10 monoclonal antibody specifically recognizes human CD161 which is also known as Natural killer cell surface protein P1A (NKR-P1A or NKRP1A) or C-type lectin domain family 5 member B (CLEC5B). CD161 is expressed on the cell surface as an 80 kDa disulfide-linked homodimeric type II transmembrane glycoprotein. It is encoded by KLRB1 (Killer cell lectin-like receptor subfamily B member 1) which belongs to the Ca2+-dependent C-type lectin superfamily. CD161 is expressed on NK cells and on subsets of CD4+ and CD8+ αβ T cells, NKT cells, γδ T cells, CD3+ thymocytes, and fetal liver cells. CD161 is preferentially expressed on memory/effector T cells. CD161 can reportedly inhibit NK cell-mediated cytotoxicity and IFN-γ production. Lectin-like transcript 1 (LLT-1), encoded by CLEC2D (C-type lectin domain family 2 member D), has been described as a ligand for CD161. LLT-1 is expressed on some activated dendritic cells (DC) and B cells.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.